We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Deaths Caused by the 2009 Flu Pandemic Greatly Exceeded WHO Estimates

By HospiMedica International staff writers
Posted on 09 Dec 2013
Image: Electron micrograph showing the 2009 H1N1 virus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Image: Electron micrograph showing the 2009 H1N1 virus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
A new estimate suggests that the global death toll from the 2009 outbreak of the H1N1 virus to be 10 times higher than the World Health Organization’s reckoning, which was based only on laboratory-confirmed cases.

A team of researchers comprising more than 60 collaborators in 26 countries analyzed weekly virology data from the World Health Organization (WHO) FluNet database and national influenza centers to identify influenza active periods, and obtained weekly national underlying cause-of-death time series for 2005–2009 from collaborators in more than 20 countries (35% of the world's population).

The investigators employed a multivariate linear regression model to measure the numbers and rates of pandemic influenza respiratory deaths in each of these countries. Then, in the second stage of their analysis, they used a multiple imputation model that took into account country-specific geographical, economic, and health indicators to project the single-country estimates to all world countries.

The WHO reported 18,631 laboratory-confirmed pandemic deaths, but the total pandemic mortality burden was substantially higher. The results of the current study yielded an estimate that between 123,000 and 203,000 pandemic influenza respiratory deaths occurred globally from April 1, 2009, through December 31, 2009. Most of these deaths (62%–85%) occurred in people younger than 65 years old. There was a striking regional heterogeneity in deaths, with up to 20-fold higher mortality in Central and South American countries than in European countries. The model attributed 148,000–249,000 respiratory deaths to influenza in an average prepandemic season. Notably, only 19% of these deaths occurred in people younger than 65 years old.

“This study confirms that the H1N1 virus killed many more people globally than originally believed,” said first author Dr. Lone Simonsen, professor of global health epidemiology at George Washington University (Washington DC, USA). “We also found that the mortality burden of this pandemic fell most heavily on younger people and those living in certain parts of the Americas.”

“Whenever a new influenza virus emerges the ensuing outbreak can represent a crisis—with rapidly spreading illness and death that spreads from country to country,” said Dr. Simonsen. “The 1918 Spanish influenza pandemic, for example, killed approximately 2% of the world population at the time or a staggering 50 million. Although the H1N1 flu did not come close to causing that high casualty rate, understanding the global impact of such a pandemic remains vitally important in order to plan and prepare for the next time a pandemic virus emerges.”

The study was published in the November 26, 2013, online edition of the journal PLOS Medicine.

Related Links:

George Washington University
World Health Organization (WHO) FluNet database


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
New
Pressure Guidewire
SavvyWire

Channels

Surgical Techniques

view channel
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more